Litigation Details for Allergan, Inc. v. Actavis plc (E.D. Tex. 2014)
✉ Email this page to a colleague
Allergan, Inc. v. Actavis plc (E.D. Tex. 2014)
Docket | ⤷ Try a Trial | Date Filed | 2014-05-22 |
Court | District Court, E.D. Texas | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | James Rodney Gilstrap |
Jury Demand | Plaintiff | Referred To | |
Patents | 8,633,162; 8,642,556; 8,648,048; 8,685,930 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Allergan, Inc. v. Actavis plc
Details for Allergan, Inc. v. Actavis plc (E.D. Tex. 2014)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2014-05-22 | 1 | Exhibit 1 U.S. Patent No. 8,633,162 | 1 U.S. Patent No. 8,633,162, # 3 Exhibit 2 U.S. Patent No. 8,642,556, # 4 Exhibit 3 U.S. Patent No. 8,…8,648,048, # 5 Exhibit 4 U.S. Patent No. 8,685,930, # 6 Exhibit 5 redacted copy of the purported April…# 10 Exhibit 9 print out from FDAs Paragraph IV Patent Certifications Database)(Hill, Jack) (Entered: … 22 May 2014 2:14-cv-00638-JRG Patent Plaintiff District Court, E.D | External link to document |
2014-12-23 | 97 | U.S. Patent. No. 8,633,162); Dkt. No. 1-3 (U.S. Patent No. 8,642,556); Dkt. No. 1-4 (U.S. Patent. No.…] for a drug claimed in a patent or the use of which is claimed in a patent. This provision creates a…I) that the required patent information has not been filed, (II) that the patent has expired, (III) that… that the patent will expire on a particular date, or (IV) that the patent is invalid, unenforceable …the interim, the U.S. Patent and Trademark Office issued four additional patents relating to RESTASIS | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |